Found: 69
Select item for more details and to access through your institution.
Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.
- Published in:
- Yonago Acta Medica, 2023, v. 66, n. 4, p. 422, doi. 10.33160/yam.2023.11.007
- By:
- Publication type:
- Article
Reply from the authors.
- Published in:
- Hepatology Research, 2020, v. 50, n. 12, p. 1393, doi. 10.1111/hepr.13578
- By:
- Publication type:
- Article
Real‐world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus‐related decompensated cirrhosis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 11, p. 1234, doi. 10.1111/hepr.13555
- By:
- Publication type:
- Article
Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients.
- Published in:
- Hepatology Research, 2020, v. 50, n. 11, p. 1222, doi. 10.1111/hepr.13554
- By:
- Publication type:
- Article
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 251, doi. 10.1159/000528145
- By:
- Publication type:
- Article
Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAIL.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 5, p. 686, doi. 10.1093/infdis/jiac044
- By:
- Publication type:
- Article
Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262675
- By:
- Publication type:
- Article
Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma.
- Published in:
- Internal Medicine, 2023, v. 62, n. 12, p. 1771, doi. 10.2169/internalmedicine.9581-22
- By:
- Publication type:
- Article
Incidence of microsatellite instability‐high hepatocellular carcinoma among Japanese patients and response to pembrolizumab.
- Published in:
- Hepatology Research, 2020, v. 50, n. 7, p. 885, doi. 10.1111/hepr.13496
- By:
- Publication type:
- Article
Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2018, v. 48, n. 13, p. 1118, doi. 10.1111/hepr.13232
- By:
- Publication type:
- Article
Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus‐related cirrhosis.
- Published in:
- Hepatology Research, 2018, v. 48, n. 4, p. 264, doi. 10.1111/hepr.12996
- By:
- Publication type:
- Article
Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.
- Published in:
- Hepatology Research, 2016, v. 46, n. 12, p. 1256, doi. 10.1111/hepr.12681
- By:
- Publication type:
- Article
Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.
- Published in:
- Hepatology Research, 2016, v. 46, n. 9, p. 944, doi. 10.1111/hepr.12629
- By:
- Publication type:
- Article
Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2015, v. 45, n. 6, p. 656, doi. 10.1111/hepr.12400
- By:
- Publication type:
- Article
Disseminated carcinomatosis of the bone marrow originating from hepatocellular carcinoma. A case report.
- Published in:
- Hepatology Research, 2015, v. 45, n. 6, p. 705, doi. 10.1111/hepr.12391
- By:
- Publication type:
- Article
Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2015, v. 45, n. 6, p. 607, doi. 10.1111/hepr.12392
- By:
- Publication type:
- Article
Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2014, v. 44, n. 14, p. E420, doi. 10.1111/hepr.12330
- By:
- Publication type:
- Article
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
- Published in:
- Hepatology Research, 2014, v. 44, n. 14, p. E447, doi. 10.1111/hepr.12336
- By:
- Publication type:
- Article
Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib.
- Published in:
- Hepatology Research, 2014, v. 44, n. 13, p. 1320, doi. 10.1111/hepr.12307
- By:
- Publication type:
- Article
Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long-term outcomes in 14 patients.
- Published in:
- Hepatology Research, 2014, v. 44, n. 7, p. 740, doi. 10.1111/hepr.12181
- By:
- Publication type:
- Article
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib.
- Published in:
- Oncology, 2023, v. 101, n. 8, p. 491, doi. 10.1159/000530991
- By:
- Publication type:
- Article
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 507, doi. 10.1159/000515865
- By:
- Publication type:
- Article
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 491, doi. 10.1159/000515280
- By:
- Publication type:
- Article
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy.
- Published in:
- Oncology, 2021, v. 99, n. 5, p. 327, doi. 10.1159/000514315
- By:
- Publication type:
- Article
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.
- Published in:
- Oncology, 2020, v. 98, n. 11, p. 787, doi. 10.1159/000509387
- By:
- Publication type:
- Article
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 9, p. 1304, doi. 10.1111/jvh.13557
- By:
- Publication type:
- Article
Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection—Pilot study.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 2, p. 400, doi. 10.1111/jvh.13441
- By:
- Publication type:
- Article
CTL‐associated and NK cell‐associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 12, p. 1555, doi. 10.1111/jvh.12970
- By:
- Publication type:
- Article
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02016-3
- By:
- Publication type:
- Article
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02616-z
- By:
- Publication type:
- Article
Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 2, p. 210, doi. 10.1002/jmv.25602
- By:
- Publication type:
- Article
Correlation between serum pro‐inflammatory cytokine levels and the prognosis of the patients with acute liver failure.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 9, p. 1637, doi. 10.1111/jgh.16300
- By:
- Publication type:
- Article
Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 3, p. 592, doi. 10.1111/jgh.15766
- By:
- Publication type:
- Article
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 6, p. 1685, doi. 10.1111/jgh.15377
- By:
- Publication type:
- Article
Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy cases.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1412, doi. 10.1111/jgh.14968
- By:
- Publication type:
- Article
Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920922051
- By:
- Publication type:
- Article
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.7025
- By:
- Publication type:
- Article
Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 5, p. 1009, doi. 10.1111/jgh.13236
- By:
- Publication type:
- Article
Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of Response Evaluation Criteria in Solid Tumors and tumor markers.
- Published in:
- Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 4, p. 726, doi. 10.1111/jgh.12821
- By:
- Publication type:
- Article
Long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration.
- Published in:
- Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 5, p. 1035, doi. 10.1111/jgh.12508
- By:
- Publication type:
- Article
Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy.
- Published in:
- Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 12, p. 1834, doi. 10.1111/jgh.12311
- By:
- Publication type:
- Article
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182710
- By:
- Publication type:
- Article
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1328, doi. 10.3390/cancers16071328
- By:
- Publication type:
- Article
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5406, doi. 10.3390/cancers15225406
- By:
- Publication type:
- Article